Aditxt, Synaptogenix leads healthcare gainers; UpHealth, Unity Biotechnology among major losers

Stock Information for null

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About null

OpGen Receives Expected Nasdaq Notice Regarding Delayed Form 10-Q
OpGen Announced 1-for-10 Reverse Stock Split
OpGen Provides Update on Business Operations and Strategic Opportunities
OpGen Receives Nasdaq Notice Regarding Delayed Form 10-K
OpGen Announces Acquisition of Preferred Stock by David Lazar
OpGen Reports Third Quarter 2023 Financial Results and Provides Business Update
OpGen Enters Into Warrant Inducement Transaction for up to $11.2 Million in Gross Proceeds
OpGen Reports Second Quarter 2023 Financial Results and Provides Business Update

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.